Utrecht-based Laigo Bio closes an extended seed round to advance protein degradation technologies for next-generation targeted therapies.
Author: Elyse Christian
UK-based Dexory raises €9.8M to expand its autonomous warehouse robots and real-time data intelligence platform across Europe and global logistics hubs.
Berlin-based biotech startup Cellbricks secures €10M led by Silicon Roundabout to accelerate 3D-printed tissue implants and future organ replacement.
German biotech iDEL Therapeutics secures €9M to build a next‑generation cancer therapeutics platform targeting hard‑to‑treat tumors.
Zurich-based Rivia raises €13M to scale its agentic data engine, aiming to streamline complex clinical trials and accelerate evidence generation for new therapies.
Utrecht-based Scinus Group raises €3M to expand its automated cell therapy platform, aiming to make advanced treatments more scalable and affordable.
Belgian startup Ternary Therapeutics raises €4.1M to design AI-driven molecular glues targeting previously ‘undruggable’ proteins in cancer and other diseases.
German biotech Kupando raises €10M to develop cancer therapies modeled on animal immune defenses, aiming to unlock new treatment options for hard-to-treat tumors.
Swedish climate startup Volta Greentech secures €1.7 million to scale its seaweed-based feed additive designed to slash methane emissions from cattle.
UK-based Cocoon Carbon announces a scalable supply of low‑carbon cement substitutes, targeting the construction sector’s emissions-heavy materials.